KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia launches new paxalisib phase II clinical trial, page-4

  1. dking99
    375 Posts.
    lightbulb Created with Sketch. 120
    clock Created with Sketch.
    15/06/21
    09:18
    Post #: 53839680
    KAZIA ENTERS CLINICAL COLLABORATION WITH CORNELL UNIVERSITY FOR PHASE II CLINICAL STUDY USING PAXALISIB IN COMBINATION WITH KETOGENIC DIET FOR GLIOBLASTOMA

    KZA Price at posting: $1.31 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
MIN MinRes jumps 5% as the company meets production guidance – depressed iron ore prices be damned
right-arrow Created with Sketch.
NEWS Nine staff strike as Paris Olympic coverage begins
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
HRZ Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.